Atlas Trials

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder

Clinical trial NCT01504659 · TERMINATED

Trial details

NCT number
NCT01504659
Sponsor
Juvenile Bipolar Research Foundation
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2012-07-01
Primary completion
2016-11-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.